Status: Not yet recruiting
Adjuvant Clopidogrel in Staphylococcus Aureus Bacteremia
The CLOPI-SNAP study is a randomized, multicenter, open-label clinical trial embedded within the SNAP (NCT 05137119) research platform. It constitutes a sub-study added to the core protocol for patients suffering Staphylococcus aureus bacteremia (SAB).
Participants needed: 230
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Fundación Pública Andaluza para la gestión de la Investigación en SevillaUpdated: Feb 5, 2026Locations: 20
Eligibility criteria
Microbiological isolation: Presence of Staphylococcus aureus complex in at least... [+2]
Allergies: Known hypersensitivity to thienopyridines (clopidogrel, prasugrel, ti... [+8]